¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2032³â)
Induced Pluripotent Stem Cells Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ±Ô¸ð´Â 2025³â 32¾ï ´Þ·¯¿¡ À̸£°í, 2025-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 7.50%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÇ¾î 2032³â¿¡´Â 53¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
¼¼°è iPS ¼¼Æ÷ ½ÃÀåÀº ¾à¹° Å×½ºÆ®, Áúº´ ¸ðµ¨¸µ, Àç»ý ÀÇÇÐ ¹× µ¶¼º Å×½ºÆ®¿¡ »ç¿ëµÇ´Â Ư¼ö ¼¼Æ÷ À¯ÇüÀ» »ý¼ºÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ³Î¸® Á߿伺ÀÌ Áõ°¡Çϰí ÀÖ´Â iPSC¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ÀÌ ½ÃÀåÀº Áٱ⼼Æ÷ ¿¬±¸ÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú »ý¸í°úÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡ÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÇâÈÄ ½ÃÀå ¼ºÀåÀº Áúº´ ¹ß°ß, ½Å¾à °³¹ß ¹× ¸ÂÃã ÀÇ·á¿¡¼ iPSCÀÇ ¿ªÇÒ¿¡ ´ëÇÑ ÀÌÇØ¿¡ ÃÊÁ¡À» ¸ÂÃß´Â Çмú ¹× »ó¾÷ ±â°ü¿¡ ÀÇÇØ ÃËÁøµÉ °ÍÀÔ´Ï´Ù.
¼¼°è iPS ¼¼Æ÷ ½ÃÀåÀº ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ Àç»ýÀÇ·á¿Í Áúº´ ¸ðµ¨¸µ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Áٱ⼼Æ÷¸¦ ÀÌ¿ëÇÑ Ä¡·á¿¡ ÁýÁßÇÏ´Â ±â¾÷ÀÌ ´Ã¾î³²¿¡ µû¶ó iPS ¼¼Æ÷¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, iPSC ±â¼úÀÇ ¹ßÀüÀ¸·Î ¾à¹° ½ºÅ©¸®´×ÀÇ È¿À²¼ºÀÌ ³ô¾ÆÁ® µ¿¹° ¸ðµ¨¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³·¾ÆÁö°í ÀüÀÓ»ó½ÃÇèÀÌ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì¿Í À¯·´¿¡¼ ÁøÇàµÇ°í ÀÖ´Â ¿¬±¸¿Í ȯÀÚ Æ¯ÀÌÀû ¾à¹° ½ºÅ©¸®´×¿¡ iPSC¸¦ »ç¿ëÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå È®´ë¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, iPSC¸¦ ÅëÇØ ȯÀÚº° Áúº´ ¸ðµ¨¸µ°ú ¾à¹° ÀÓ»ó½ÃÇèÀÌ °¡´ÉÇØÁü¿¡ µû¶ó °³ÀθÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿äµµ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ź·ÂÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
iPS ¼¼Æ÷ ½ÃÀåÀº ƯÈ÷ »ý¸í°øÇÐ ¹× Á¦¾à »ê¾÷ÀÇ Áö¼ÓÀûÀÎ ¼ºÀå°ú ÇÔ²² Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. iPS ¼¼Æ÷´Â Áúº´ ¸ÞÄ¿´ÏÁòÀÌ ¹àÇôÁö¸é¼ °³ÀÎ ¸ÂÃãÇü ÀǾàǰ °³¹ß ¹× Áúº´ Ä¡·á¿¡ µ¶Æ¯ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ´ëÇаú ¿¬±¸±â°üÀÇ ±âÃÊ¿¬±¸¿¡ ´ëÇÑ Ãß°¡ ÅõÀÚ´Â iPSC¸¦ ¾î¶»°Ô Ȱ¿ëÇϸé Áúº´ °úÁ¤À» ´õ ±íÀÌ ÀÌÇØÇÒ ¼ö ÀÖ´ÂÁö¿¡ ´ëÇÑ »õ·Î¿î ÅëÂû·ÂÀ» Á¦°øÇÏ¿© »õ·Î¿î Ä¡·á Àü·«À¸·Î À̾îÁú ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ¶ÇÇÑ, µ¶¼º½ÃÇè°ú ÀÓ»ó½ÃÇè¿¡¼ iPSCÀÇ »ç¿ë È®´ë´Â Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. »ý¸í°øÇÐ ±â¾÷°ú ¿¬±¸±â°üÀÇ Çù·ÂÀº ½ÃÀå ÀáÀç·ÂÀ» ´õ¿í ³ôÀ̰í iPSC ±â¹Ý ÀÀ¿ë ºÐ¾ßÀÇ »ó¿ëȸ¦ °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â Àü ¼¼°è Àΰø¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ¼¼Æ÷ À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå ¼·Ð
Á¦3Àå À¯µµ¸¸´ÉÁٱ⼼Æ÷ ½ÃÀå ±âȸ ºÐ¼®
Á¦4Àå ½ÃÀå ¹è°æ
Á¦5Àå °Å½Ã°æÁ¦ ÀüÁ¦
Á¦6Àå ¼¼°è °æÁ¦ Àü¸Á
Á¦7Àå ÁÖ¿ä ³»¿ë
Á¦8Àå ºÏ¹ÌÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦10Àå À¯·´ÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦12Àå Áß±¹ÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦13Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦14Àå ¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ
Á¦15Àå ¿¹ÃøÀÇ ÀüÁ¦Á¶°Ç
Á¦16Àå ½ÃÀå ±¸Á¶ ºÐ¼®
Á¦17Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
±â¾÷ »ó¼¼
Thermo Fisher Scientific Inc.
FUJIFILM Holdings Corporation(Cellular Dynamics)
Horizon Discovery Group plc.
Takara Bio Inc.
Cell Applications, Inc.
Lonza Group Ltd.
Á¦18Àå ¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â), Áö¿ªº°
Á¦19Àå ¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷ ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â), ¼¼Æ÷ À¯Çüº°
Á¦20Àå ¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â), ¿ëµµº°
Á¦21Àå ¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â), ÃÖÁ¾»ç¿ëÀÚº°
Á¦22Àå ¼¼°èÀÇ À¯µµ¸¸´ÉÁٱ⼼Æ÷(iPS ¼¼Æ÷) ½ÃÀå ºÐ¼®(2020³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)
Á¦23Àå °¡Á¤°ú µÎÀÚ¾î
Á¦24Àå Á¶»ç ¹æ¹ý
LSH
Persistence Market Research has recently released a comprehensive report on the global iPS Cell Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
Induced Pluripotent Stem Cell Market Size (2025E): USD 3.2 Billion
Projected Market Value (2032F): USD 5.3 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 7.50%
Induced Pluripotent Stem Cell Market- Report Scope:
The global iPS cell market is focused on induced pluripotent stem cells (iPSCs), which are gaining widespread importance for their ability to generate specialized cell types used for drug testing, disease modeling, regenerative medicine, and toxicity testing. This market is influenced by ongoing advancements in stem cell research and increasing investments in life sciences. The market's future growth is fueled by both academic and commercial entities' focus on understanding the roles of iPSCs in disease development, drug discovery, and personalized medicine.
Market Drivers:
The global iPS cell market is witnessing significant growth due to various factors. A key driver is the increasing investment in life science research, particularly the growing emphasis on regenerative medicine and disease modeling. With more companies focusing on stem cell-based therapies, the demand for iPSCs is expected to rise. In addition, advancements in iPSC technology have made drug screening more efficient, reducing the reliance on animal models and improving preclinical testing. Moreover, the ongoing research in North America and Europe, as well as the rising use of iPSCs for patient-specific drug screening, supports the expansion of the market. The demand for personalized medicine is also expected to provide further momentum to market growth, as iPSCs allow for patient-specific disease modeling and drug testing.
Market Restraints:
Despite the promising growth trajectory, the iPS cell market faces some hurdles. One of the primary challenges is the complexity and cost associated with iPSC production and maintenance, which may limit accessibility for smaller research institutions or emerging biotech firms. Additionally, ethical concerns surrounding stem cell research, along with stringent regulatory frameworks, can impede market expansion. There is also a need for improved standardization and protocols in iPSC generation, differentiation, and application to ensure consistency and reproducibility in research. These challenges are expected to be addressed through ongoing research, technological improvements, and evolving regulatory support.
Market Opportunities:
The iPS cell market offers substantial opportunities, particularly with the continued growth of the biotechnology and pharmaceutical industries. With an increased understanding of disease mechanisms, iPSCs offer unique opportunities for personalized drug development and disease treatment. Further investment in basic research, especially in academia and research institutes, is expected to provide fresh insights into how iPSCs can be used to better understand disease processes, leading to new therapeutic strategies. Additionally, the growing use of iPSCs in toxicity testing and clinical trials presents significant growth opportunities. The increasing collaboration between biotech firms and research institutes further enhances market potential, accelerating the commercialization of iPSC-based applications.
Key Questions Answered in the Report:
What are the primary factors driving the global growth of the iPS cell market?
How are advancements in stem cell technology influencing iPS cell-based applications?
Which regions are seeing the highest demand for iPS cells in drug testing, regenerative medicine, and toxicity screening?
What are the challenges and limitations associated with iPSC technology, and how can these be overcome?
Who are the key players in the iPS cell market, and what strategies are they employing to expand their market presence?
What are the emerging trends and future projections for the global iPS cell market?
Competitive Intelligence and Business Strategy:
Leading companies in the global iPS cell market are focusing on enhancing their research capabilities and expanding product portfolios. Key players such as FUJIFILM Cellular Dynamics, Stemcell Technologies, and ReproCELL are investing heavily in advancing iPSC technologies and developing solutions tailored to drug discovery and regenerative medicine. Strategic partnerships and collaborations with academic institutions and research organizations play a critical role in accelerating product development and market reach. These companies are also exploring innovative applications of iPSCs in disease modeling and personalized treatments, positioning themselves as leaders in the expanding life sciences field.
Key Companies Profiled:
Thermo Fisher Scientific Inc.
FUJIFILM Holdings Corporation (Cellular Dynamics)
Horizon Discovery Group plc.
Takara Bio Inc.
Cell Applications, Inc.
Lonza Group Ltd.
Others.
Induced Pluripotent Stem Cell Market Segmentation:
By Cell Type:
Hepatocytes
Fibroblasts
Keratinocytes
Neurons
Others
By Application:
Drug Development
Regenerative Medicine
Toxicity Testing
By End User:
Academic and Research Institutes
Biotechnology Companies
By Region:
North America
Latin America
Europe
Asia Pacific excluding China (APEC)
China
Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Induced Pluripotent Stem cells Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Parent Market Overview
4.2. Induced Pluripotent Stem Cell Timeline
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
5. Macroeconomic Assumptions
6. Global Economic Outlook
6.1. Gross Domestic Product by Region & Country, 2025 - 2032
6.2. Healthcare Indicators
7. Key Inclusions
7.1. Usage Trend in Industry
7.2. Active Researchers in Stem Cell Research
7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
7.5. Pipeline Assessment
8. North America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
8.3.1. U.S.
8.3.2. Canada
8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
8.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
8.5.1. Hepatocytes
8.5.2. Fibroblasts
8.5.3. Keratinocytes
8.5.4. Neurons
8.5.5. Others
8.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
8.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
8.7.1. Drug Development
8.7.2. Toxicity testing
8.7.3. Regenerative Medicine
8.7.4. Others
8.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
8.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
8.9.1. Academic & Research Institutes
8.9.2. Biotechnology companies
8.9.3. Others
8.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
8.11. Drivers and Restraints: Impact Analysis
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Cell Type
8.12.3. By Application
8.12.4. By End User
8.13. Key Market Participants - Intensity Mapping
8.14. Drivers and Restraints - Impact Analysis
9. Latin America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
9.3.1. Argentina
9.3.2. Brazil
9.3.3. Mexico
9.3.4. Rest of Latin America
9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
9.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
9.5.1. Hepatocytes
9.5.2. Fibroblasts
9.5.3. Keratinocytes
9.5.4. Neurons
9.5.5. Others
9.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
9.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
9.7.1. Drug Development
9.7.2. Toxicity testing
9.7.3. Regenerative Medicine
9.7.4. Others
9.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
9.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
9.9.1. Academic & Research Institutes
9.9.2. Biotechnology companies
9.9.3. Others
9.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
9.11. Drivers and Restraints: Impact Analysis
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Cell Type
9.12.3. By Application
9.12.4. By End User
9.13. Key Market Participants - Intensity Mapping
9.14. Drivers and Restraints - Impact Analysis
9.15. Key Mergers & Acquisitions
10. Europe Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
10.3.1. Germany
10.3.2. U.K.
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
10.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
10.5.1. Hepatocytes
10.5.2. Fibroblasts
10.5.3. Keratinocytes
10.5.4. Neurons
10.5.5. Others
10.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
10.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
10.7.1. Drug Development
10.7.2. Toxicity testing
10.7.3. Regenerative Medicine
10.7.4. Others
10.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
10.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
10.9.1. Academic & Research Institutes
10.9.2. Biotechnology companies
10.9.3. Others
10.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
10.11. Drivers and Restraints: Impact Analysis
10.12.Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Cell Type
10.12.3. By Application
10.12.4. By End User
10.13. Key Market Participants - Intensity Mapping
10.14. Drivers and Restraints - Impact Analysis
10.15. Key Mergers & Acquisitions
11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
11.3.1. Japan
11.3.2. India
11.3.3. Australia and New Zealand
11.3.4. Rest of Asia Pacific
11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
11.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
11.5.1. Hepatocytes
11.5.2. Fibroblasts
11.5.3. Keratinocytes
11.5.4. Neurons
11.5.5. Others
11.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
11.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
11.7.1. Drug Development
11.7.2. Toxicity testing
11.7.3. Regenerative Medicine
11.7.4. Others
11.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
11.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
11.9.1. Academic & Research Institutes
11.9.2. Biotechnology companies
11.9.3. Others
11.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
11.11. Drivers and Restraints: Impact Analysis
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Cell Type
11.12.3. By Application
11.12.4. By End User
11.13. Key Market Participants - Intensity Mapping
11.14. Drivers and Restraints - Impact Analysis
11.15. Key Mergers & Acquisitions
12. China Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
12.1. Introduction
12.2. Key Regulations
12.3. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
12.3.1. Hepatocytes
12.3.2. Fibroblasts
12.3.3. Keratinocytes
12.3.4. Neurons
12.3.5. Others
12.4. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
12.5. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
12.5.1. Drug Development
12.5.2. Toxicity testing
12.5.3. Regenerative Medicine
12.5.4. Others
12.6. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
12.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
12.7.1. Academic & Research Institutes
12.7.2. Biotechnology companies
12.7.3. Others
12.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
12.9. Drivers and Restraints: Impact Analysis
12.10. Market Attractiveness Analysis
12.10.1. By Cell Type
12.10.2. By Application
12.10.3. By End User
12.11. Key Market Participants - Intensity Mapping
12.12. Drivers and Restraints - Impact Analysis
12.13. Key Mergers & Acquisitions
13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
13.1. Introduction
13.2. Key Regulations
13.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of MEA
13.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
13.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
13.5.1. Hepatocytes
13.5.2. Fibroblasts
13.5.3. Keratinocytes
13.5.4. Neurons
13.5.5. Others
13.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
13.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
13.7.1. Drug Development
13.7.2. Toxicity testing
13.7.3. Regenerative Medicine
13.7.4. Others
13.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
13.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
13.9.1. Academic & Research Institutes
13.9.2. Biotechnology companies
13.9.3. Others
13.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
13.11. Drivers and Restraints: Impact Analysis
13.12. Market Attractiveness Analysis
13.12.1. By Country
13.12.2. By Cell Type
13.12.3. By Application
13.12.4. By End User
13.13. Key Market Participants - Intensity Mapping
13.14. Drivers and Restraints - Impact Analysis
13.15. Key Mergers & Acquisitions
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Market Structure Analysis
16.1. Market Structure by Tier of Companies
16.2. Market Share Analysis (2024) for Top Players, By Region
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Company Deep Dive
17.3.1. Thermo Fisher Scientific Inc.
17.3.1.1. Overview
17.3.1.2. Product and Application Portfolio
17.3.1.3. Production Footprint
17.3.1.4. Sales Footprint
17.3.1.5. Channel Footprint
17.3.1.6. Strategy
17.3.1.6.1. Marketing Strategy
17.3.1.6.2. Product Strategy
17.3.1.6.3. Channel Strategy
17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
17.3.2.1. Overview
17.3.2.2. Product and Application Portfolio
17.3.2.3. Production Footprint
17.3.2.4. Sales Footprint
17.3.2.5. Channel Footprint
17.3.2.6. Strategy
17.3.2.6.1. Marketing Strategy
17.3.2.6.2. Product Strategy
17.3.2.6.3. Channel Strategy
17.3.3. Horizon Discovery Group plc.
17.3.3.1. Overview
17.3.3.2. Product and Application Portfolio
17.3.3.3. Production Footprint
17.3.3.4. Sales Footprint
17.3.3.5. Channel Footprint
17.3.3.6. Strategy
17.3.3.6.1. Marketing Strategy
17.3.3.6.2. Product Strategy
17.3.3.6.3. Channel Strategy
17.3.4. Takara Bio Inc.
17.3.4.1. Overview
17.3.4.2. Product and Application Portfolio
17.3.4.3. Production Footprint
17.3.4.4. Sales Footprint
17.3.4.5. Channel Footprint
17.3.4.6. Strategy
17.3.4.6.1. Marketing Strategy
17.3.4.6.2. Product Strategy
17.3.4.6.3. Channel Strategy
17.3.5. Cell Applications, Inc.
17.3.5.1. Overview
17.3.5.2. Product and Application Portfolio
17.3.5.3. Production Footprint
17.3.5.4. Sales Footprint
17.3.5.5. Channel Footprint
17.3.5.6. Strategy
17.3.5.6.1. Marketing Strategy
17.3.5.6.2. Product Strategy
17.3.5.6.3. Channel Strategy
17.3.6. Lonza Group Ltd.
17.3.6.1. Overview
17.3.6.2. Product and Application Portfolio
17.3.6.3. Production Footprint
17.3.6.4. Sales Footprint
17.3.6.5. Channel Footprint
17.3.6.6. Strategy
17.3.6.6.1. Marketing Strategy
17.3.6.6.2. Product Strategy
17.3.6.6.3. Channel Strategy
18. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Region
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2020 - 2024
18.3. Market Size (US$ Bn) Forecast By Region, 2025 - 2032
18.3.1. North America
18.3.2. Latin America
18.3.3. Europe
18.3.4. Asia Pacific
18.3.5. Middle East & Africa
18.3.6. China
18.4. Market Attractiveness Analysis By Region
19. Global Induced Pluripotent Stem Cells Analysis 2020 - 2024 and Forecast 2025 - 2032, By Cell Type
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
19.2.1. Hepatocytes
19.2.2. Fibroblasts
19.2.3. Keratinocytes
19.2.4. Neurons
19.2.5. Others
19.3. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
19.4. Market Attractiveness Analysis By Cell Type
20. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Application
20.1. Introduction/Key Findings
20.2. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
20.2.1. Drug Development
20.2.2. Toxicity testing
20.2.3. Regenerative Medicine
20.2.4. Others
20.3. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
20.4. Market Attractiveness Analysis By Application
21. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By End User
21.1. Introduction/Key Findings
21.2. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
21.2.1. Academic & Research Institutes
21.2.2. Biotechnology companies
21.2.3. Others
21.3. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
21.4. Market Attractiveness Analysis By End User
22. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
22.1. Market Value Share Analysis By All Segment
22.2. Y-o-Y Growth Analysis By All Segment
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms
24. Research Methodology